Table 5

Comparison of the initial gradients for the concentration dependence of the effect of amilorides on the dissociation of [3H]prazosin or [3H]yohimbine from the α1A- or α2A-adrenergic receptors, respectively

Amiloridenα1A-Adrenergic Receptorα2A-Adrenergic Receptor
Initial Gradient K2 ∗ (k−2k−1)Affinity ∗ Fold Increase K2 ∗ (k−2k−1)/k−1Initial GradientK2 ∗ (k−2k−1)Affinity ∗ Fold Increase K2 ∗ (k−2k−1)/k−1
Amiloride443  ± 32,1003.4101
DMA6102  ± 54,900341,010
BZA2141  ± 36,70011310
EPA2186  ± 38,8002707,900
MBA2187  ± 28,90040012,000
HMA3393  ± 2019,0001,10032,000

For the α1A-adrenergic receptor, the initial gradient estimates were derived as described in the legend of Fig. 5, and are expressed as means ± S.E. of n experiments. For the α2A-adrenergic receptor, the values were calculated with published data (Leppik et al., 1998). To enable comparison, each estimate was divided by the antagonist dissociation rate (k −1) in the absence of amiloride analog (0.0212 ± 0.0004 min−1 for [3H]prazosin/α1A-adrenergic receptor, 0.034 ± 0.001 min−1 for [3H]yohimbine/α2A-adrenergic receptor). Thek −2 is the antagonist dissociation rate from the amiloride analog-occupied receptor, and K 2 is the affinity of the amiloride analog at the antagonist-occupied receptor.